Arnold Munnich
12Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Oct 19, 1995 → Dec 27, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6824972B2 | Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-&kgr;B) activation | Physics | 27 | Expired |
| US6080577A | Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy | Emerging Cross-Sectional Technologies | 19 | Expired |
| US7033752B1 | Spinal muscular atrophy diagnostic methods | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6040142A | Method and probes for detecting markers linked to the infantile spinal muscular atrophy locus | Chemistry; Metallurgy | 15 | Expired |
| US8394932B2 | Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy | Emerging Cross-Sectional Technologies | 2 | Active |
| US8962269B2 | Spinal muscular atrophy diagnostic methods | Emerging Cross-Sectional Technologies | 2 | Active |
| US9834820B2 | Methods for the treatment and diagnosis of bone mineral density related diseases | Chemistry; Metallurgy | 1 | Active |
| US9931341B2 | Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3 | Chemistry; Metallurgy | 0 | Active |
| US11357778B2 | Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3 | Chemistry; Metallurgy | 0 | Active |
| US11857532B2 | Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxia | Human Necessities | 0 | Active |
| US8097287B2 | Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of genetic origin | Human Necessities | 0 | Active |
| US11667913B2 | Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.